LFWD NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

ReWalk Robotics Ltd · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 7.22 USD
2.4% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 2.2% above the Trend Line and sits at 48.0% of its 52-week range. The latest completed week returned 2.4%, after a -10.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 60/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 28 out of 100
Latest Close 7.22 USD 31 Jul 2026
1W Return 2.4% latest completed week
4W Return -10.0% short-term follow-through
12W Return 14.6% quarterly tape
Trend Breadth 5.8% 3 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 33.86% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.4% Latest completed week; four-week move -10.0%. Indicator stack 14/68 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 33.86% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 60/100 38 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 2.2% above the Trend Line and sits at 48.0% of its 52-week range. The latest completed week returned 2.4%, after a -10.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4012-week average 0.27

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.40Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -10.0% over four weeks, 14.6% over 12 weeks, and -13.6% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W2.4%
4W-10.0%
12W14.6%
26W-0.6%
52W-13.6%
Active trend streak3 weeks
Active weeks in one year3
Trend breadth5.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.03Latest activity-pressure read.
Pressure change-10.2%Four-week change in activity pressure.
Leadership-9.76Latest relative-leadership reading.
RS change-56.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength78/100Blend of value, momentum, and quality. Underlying universe rank 23; rank 1 is best.
Value64/100Relative valuation strength. Underlying universe rank 37; rank 1 is best.
Quality62/100Profitability and accounting quality. Underlying universe rank 39; rank 1 is best.
Momentum64/100Medium-term price momentum. Underlying universe rank 37; rank 1 is best.
Growth64/100Revenue and earnings growth. Underlying universe rank 37; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-87.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
36.6%
Gross profit retained from each unit of revenue.
Operating margin
-106.0%
Operating profit retained from revenue.
Free-cash-flow margin
-71.7%
Free cash flow generated from revenue.
Return on invested capital
-451.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-17.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-38.9%
Net share repurchases relative to market value.
Shareholder yield
-38.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment60/100

Weighted news tone is neutral across 38 relevant articles.

13 positive · 23 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-31.6%Distance below the 52-week high.
13-week volatility8.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+45.1%Week of 27 Feb.
Worst week-18.9%Week of 6 Mar.
Latest week+2.4%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains3
Flat weeks0
Modest losses3
Sharp losses10
Recent vol8.2%13-week weekly-return volatility.
Base vol11.7%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew11.2% / -7.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis43/100

Latest 12-week confirmation: trend 3/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.40; No reversal markers Next-Week ExpectancyNegative 33.86%

Next-week expectancy is negative with a 33.86% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors67/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 95 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment60/100

Weighted news tone is neutral across 38 relevant articles.

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings11d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20267.22 USD2.4%7.06 USD30.62 USD1.03-9.7620.1KOn
24 Jul 20267.05 USD-10.9%7.07 USD30.94 USD1.21-12.0837.4KOn
17 Jul 20267.91 USD-5.7%7.09 USD31.29 USD1.32-3.9052.8KOn
10 Jul 20268.38 USD4.6%7.09 USD31.65 USD1.23-3.04203.3KOff
3 Jul 20268.02 USD11.4%7.08 USD32.02 USD1.15-6.2372.6KOff
26 Jun 20267.20 USD4.2%7.11 USD32.39 USD1.05-15.5326.9KOff
19 Jun 20266.91 USD1.9%7.10 USD32.67 USD1.07-23.1417.7KOff
12 Jun 20266.78 USD-3.2%7.08 USD32.94 USD1.11-24.2724.3KOff
5 Jun 20267.00 USD-11.8%7.09 USD33.22 USD1.07-21.8658.5KOff
29 May 20267.94 USD12.6%7.07 USD33.49 USD0.93-17.6162.1KOff
22 May 20267.05 USD5.2%7.05 USD33.76 USD0.76-26.6571.3KOff
15 May 20266.70 USD6.3%7.08 USD34.04 USD0.56-31.4138.4KOff
8 May 20266.30 USD-13.0%7.13 USD34.33 USD0.36-37.5137.5KOff
1 May 20267.25 USD-1.8%7.22 USD34.62 USD0.24-26.6627.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.